AC Immune Ltd (NASDAQ:ACIU)‘s stock had its “outperform” rating reaffirmed by investment analysts at Leerink Swann in a report issued on Saturday.
Several other equities analysts have also issued reports on the stock. Credit Suisse Group AG began coverage on shares of AC Immune in a report on Tuesday, October 18th. They issued an “outperform” rating and a $18.00 price target on the stock. Jefferies Group began coverage on shares of AC Immune in a report on Tuesday, October 18th. They issued a “buy” rating and a $25.00 price target on the stock.
AC Immune (NASDAQ:ACIU) traded up 9.37% during midday trading on Friday, hitting $12.61. The stock had a trading volume of 269,075 shares. The firm has a 50-day moving average of $14.16 and a 200 day moving average of $14.83. AC Immune has a 52-week low of $10.36 and a 52-week high of $19.97. The firm’s market capitalization is $624.74 million.